Gut Pathogens

Gut Pathogens is an open access, peer-reviewed journal published by BioMed Central, established in 2009 and devoted to the biology and medicine of the pathogens, commensals and functional microbiota of the gut, with a 2025 Journal Impact Factor of 5.0.《肠道病原体》（Gut Pathogens）由（BioMed Central）出版，2009 年创刊，为开放获取期刊，专注肠道病原体、共生菌与功能性微生物组的生物学与医学，2025 年期刊影响因子为 5.0。

Scope

• The journal covers the full breadth of research into the biology and medicine of pathogens, commensals and functional microbiota of the gut.刊物覆盖肠道病原体、共生菌与功能性微生物组的生物学与医学的完整研究面。
• Its focus includes infections caused by gastric and enteric bacteria, viruses and other causative agents.其重点包括由胃部与肠道细菌、病毒及其他致病因子引起的感染。
• Probiotic bacteria and yeasts and their products are treated as a core subject of the journal.益生菌细菌与酵母及其产物被视为刊物的核心主题。
• The related ecology, molecular genetics, physiology and epidemiology of these organisms are within scope.这些微生物的相关生态学、分子遗传学、生理学与流行病学均在其范围内。
• The journal actively invites reports on novel aspects of genomics, metagenomics, microbiota profiling and systems biology.刊物积极征集基因组学、宏基因组学、微生物组图谱与系统生物学新进展的报道。
• Basic, clinical and cutting edge research are all published, with a commitment to rapid dissemination.刊物同时发表基础研究、临床研究与前沿研究，并致力于快速传播成果。
• At the editor's discretion, manuscripts may be abridged as short reports that highlight significant observations alongside a review of the state of the art.经编辑决定，部分稿件可以短报告形式刊出，在综述领域现状的同时突出重要观察结果。

History

• Gut Pathogens was founded in 2009 under BioMed Central as a journal focused on enteric infections.《肠道病原体》2009 年在（BioMed Central）旗下创办，最初聚焦肠道感染。
• It was established with an audience in the Global South and middle income countries in mind, and its opening articles dealt with virulence, epidemiology and the genomics of classical pathogens.刊物创办时面向全球南方与中等收入国家的读者，早期论文围绕经典病原体的毒力、流行病学与基因组学。
• As probiotic research expanded, the journal became a preferred venue for work on probiotics, and later for bacterial genomics and microbiome research.随着益生菌研究的发展，刊物成为益生菌研究的首选发表平台之一，随后又转向细菌基因组学与微生物组研究。
• The journal marked its tenth anniversary in 2019, by which time its scope had broadened from enteric pathogens to functional gut microbiota.刊物于 2019 年迎来创刊十周年，其时范围已从肠道病原体扩展到功能性肠道微生物组。
• Its 2025 Journal Impact Factor is 5.0, after 4.0 in 2024 and 5.324 in 2022, with the journal ranked in the first quartile of gastroenterology and hepatology.2025 年期刊影响因子为 5.0，此前 2024 年为 4.0、2022 年为 5.324，刊物在胃肠病学与肝病学类别位列一区。
• Being fully open access, the journal charges an article processing charge and publishes under an open licence.刊物为完全开放获取，收取文章处理费并以开放许可发布。
• It is indexed in Science Citation Index Expanded, PubMed and MEDLINE, Scopus, and EMBASE.刊物被科学引文索引扩展版、PubMed 与 MEDLINE、Scopus 以及 EMBASE 收录。

Editors

• Editor-in-Chief Niyaz Ahmed, a professor at the University of Hyderabad in India, has led the journal since its foundation in 2009.主编为印度海得拉巴大学的（Niyaz Ahmed）教授，自 2009 年创刊起领导刊物。
• Ahmed is a One Health epidemiologist and molecular epidemiologist, and received India's Shanti Swarup Bhatnagar Prize in medical sciences.（Ahmed）从事同一健康与分子流行病学研究，曾获印度医学科学领域的香提·斯瓦鲁普·巴特纳格尔奖。
• Leonardo A. Sechi of the University of Sassari in Italy served as founding co-Editor-in-Chief.意大利萨萨里大学的（Leonardo A. Sechi）担任创始共同主编。
• Senior editors who do not handle manuscripts include Barry Marshall of the University of Western Australia, Francis Megraud of INSERM, and Lothar Wieler of the Robert Koch Institute.不处理稿件的资深编辑包括西澳大学的（Barry Marshall）、法国国家健康与医学研究院的（Francis Megraud）以及罗伯特·科赫研究所的（Lothar Wieler）。
• Associate editors are drawn from institutions including ICAR's National Research Centre on Meat, Amsterdam University Medical Centers, Juntendo University and the University of Muenster.副主编来自印度农业研究理事会肉类国家研究中心、阿姆斯特丹大学医学中心、顺天堂大学与明斯特大学等机构。
• Submissions are handled online by BioMed Central, with peer review conducted by external experts and published articles openly accessible.稿件由（BioMed Central）在线处理，同行评审由外部专家完成，发表文章公开可读。